Jim Breidenstein

Jim Breidenstein has extensive experience in the healthcare industry, with a focus on commercialization and business development. Jim has held leadership roles in various companies, including PainScript, Inc., where they served as President and Chief Commercial Officer, and Proem Behavioral Health, where they were Chief Growth Officer. Prior to these roles, Breidenstein was the President and CEO of BSTEIN Consulting, LLC, where they helped healthcare companies commercialize innovative products. Jim also served as VP of Global Commercial Development at Pear Therapeutics, where they led the creation of commercial strategy for software-based medical devices. Additionally, they have held executive positions at CHF Solutions, Inc., Surgical Theater, Cardiovascular Systems, Inc., Neuronetics, and Kyphon, Inc. Jim'sexperience spans a range of healthcare sectors, including digital health, behavioral health, cardiovascular, orthopedics, and neurology/neurosurgery. Breidenstein has a proven track record of successfully scaling commercial operations, building sales teams, and executing strategic plans.

Jim Breidenstein has participated in an Executive Educational Program focused on Marketing Healthcare Products at Northwestern University's Kellogg School of Management. Additionally, they hold a Bachelor of Arts degree in Business Studies from Buffalo State University. No specific start or end years are indicated for these educational experiences.